Sadahiro Ito

470 total citations
10 papers, 385 citations indexed

About

Sadahiro Ito is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sadahiro Ito has authored 10 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Sadahiro Ito's work include Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Alzheimer's disease research and treatments (2 papers) and Trace Elements in Health (2 papers). Sadahiro Ito is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Alzheimer's disease research and treatments (2 papers) and Trace Elements in Health (2 papers). Sadahiro Ito collaborates with scholars based in Japan. Sadahiro Ito's co-authors include Yasuyuki Takagi, Shin‐ichiro Honda, Nobuhiro Harada, Shuichiro Maeda, Jing Chen, Kaoru Aida, Toshimasa Onaya, Masato Tawata, Hiroaki Kawano and Shinichi Nakano and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Cardiovascular Research.

In The Last Decade

Sadahiro Ito

9 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sadahiro Ito Japan 7 176 125 106 66 55 10 385
Reymundo Dominguez United States 9 268 1.5× 128 1.0× 123 1.2× 140 2.1× 40 0.7× 11 473
Sarah Gallet France 9 53 0.3× 126 1.0× 147 1.4× 45 0.7× 55 1.0× 11 470
Ke-Wen Dong United States 15 280 1.6× 208 1.7× 278 2.6× 102 1.5× 51 0.9× 22 743
Marietta Vértes Hungary 11 163 0.9× 148 1.2× 119 1.1× 57 0.9× 68 1.2× 45 495
M Motta Italy 9 106 0.6× 108 0.9× 130 1.2× 140 2.1× 53 1.0× 21 456
Markus Lauber Switzerland 14 245 1.4× 182 1.5× 134 1.3× 274 4.2× 102 1.9× 21 611
Deepa Joshi Canada 12 50 0.3× 161 1.3× 37 0.3× 77 1.2× 36 0.7× 23 437
Jessie I. Luoma United States 8 91 0.5× 170 1.4× 42 0.4× 47 0.7× 31 0.6× 8 364
Davelene D. Israel United States 10 56 0.3× 99 0.8× 210 2.0× 36 0.5× 20 0.4× 10 506
M. Zanisi Italy 16 177 1.0× 161 1.3× 291 2.7× 242 3.7× 91 1.7× 36 713

Countries citing papers authored by Sadahiro Ito

Since Specialization
Citations

This map shows the geographic impact of Sadahiro Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sadahiro Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sadahiro Ito more than expected).

Fields of papers citing papers by Sadahiro Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sadahiro Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sadahiro Ito. The network helps show where Sadahiro Ito may publish in the future.

Co-authorship network of co-authors of Sadahiro Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Sadahiro Ito. A scholar is included among the top collaborators of Sadahiro Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sadahiro Ito. Sadahiro Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Kato, Keizo, et al.. (2021). A case of hepatocellular carcinoma caused severe tumor lysis by ramucirumab. Kanzo. 62(3). 129–135.
3.
Kashiwagi, Kenji, et al.. (2017). A Ser75-to-Asp phospho-mimicking mutation in Src accelerates ageing-related loss of retinal ganglion cells in mice. Scientific Reports. 7(1). 16779–16779. 6 indexed citations
4.
Kobayashi, Tsuyoshi, Yosuke Watanabe, Yukio Saitō, et al.. (2009). Mice lacking the glutamate-cysteine ligase modifier subunit are susceptible to myocardial ischaemia–reperfusion injury. Cardiovascular Research. 85(4). 785–795. 26 indexed citations
5.
Wei, Lan, Hiroo Kawano, Xiaoying Fu, et al.. (2004). Deposition of transthyretin amyloid is not accelerated by the same amyloidin vivo. Amyloid. 11(2). 113–120. 10 indexed citations
6.
Kawano, Hiroo, et al.. (2001). Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits. Amyloid. 8(2). 101–104. 5 indexed citations
7.
Kawano, Hiroo, Sadahiro Ito, Yoshiie Okada, et al.. (2001). Mice Lacking Serum Amyloid P Component Do Not Necessarily Develop Severe Autoimmune Disease. Biochemical and Biophysical Research Communications. 286(1). 200–205. 14 indexed citations
8.
Aida, Kaoru, Jing Chen, Masato Tawata, et al.. (2000). Disruption of Aldose Reductase Gene (Akr1b1) Causes Defect in Urinary Concentrating Ability and Divalent Cation Homeostasis. Biochemical and Biophysical Research Communications. 277(2). 281–286. 30 indexed citations
9.
Honda, Shin‐ichiro, et al.. (1998). Disruption of Sexual Behavior in Male Aromatase-Deficient Mice Lacking Exons 1 and 2 of thecyp19Gene. Biochemical and Biophysical Research Communications. 252(2). 445–449. 248 indexed citations
10.
Lim, Seung Kil, Hiroaki Kawano, Sadahiro Ito, et al.. (1997). Serum amyloid P component enhances induction of murine amyloidosis.. PubMed. 77(5). 525–31. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026